{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:32:35Z","timestamp":1789903955951,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR001102"],"award-info":[{"award-number":["UL1 TR001102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ntt.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T22:15:15Z","timestamp":1452550515000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine"],"prefix":"10.1016","volume":"54","author":[{"given":"Uma","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Dworetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis B.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ntt.2016.01.001_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ntt.2016.01.001_bb0010","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ntt.2016.01.001_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14740338.4.2.345","article-title":"Teratogenicity of sodium valproate","volume":"4","author":"Alsdorf","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ntt.2016.01.001_bb0020","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric A","year":"2013"},{"key":"10.1016\/j.ntt.2016.01.001_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.1320290123","article-title":"Verification of the fetal valproate syndrome phenotype","volume":"29","author":"Ardinger","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ntt.2016.01.001_bb0030","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/01.WNL.0000163771.96962.1F","article-title":"Antiepileptic drug use of women with epilepsy and congenital malformations in offspring","volume":"64","author":"Artama","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0040","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ntt.2016.01.001_bb0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ntt.2016.01.001_bb0055","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ntt.2016.01.001_bb0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yebeh.2011.06.014","article-title":"Fetal antiepileptic drug exposure: motor, adaptive, and emotional\/behavioral functioning at age 3years","volume":"22","author":"Cohen","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ntt.2016.01.001_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ntt.2016.01.001_bb0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ntt.2016.01.001_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humrep\/deu333","article-title":"Assisted reproduction involving gestational surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program","volume":"30","author":"Dar","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ntt.2016.01.001_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.39.4.251","article-title":"Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth","volume":"39","author":"Dean","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ntt.2016.01.001_bb0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.06.001","article-title":"Children exposed to valproate in utero\u2014population based evaluation of risks and confounding factors for long-term neurocognitive development","volume":"65","author":"Eriksson","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ntt.2016.01.001_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.62.1.28","article-title":"Normal intelligence in children with prenatal exposure to carbamazepine","volume":"62","author":"Gaily","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archneurol.2011.133","article-title":"Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations","volume":"68","author":"Holmes","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ntt.2016.01.001_bb0100","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10803-010-1126-4","article-title":"The role of adaptive behavior in autism spectrum disorders: implications for functional outcome","volume":"41","author":"Kanne","year":"2011","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.ntt.2016.01.001_bb0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10803-006-0229-4","article-title":"Social and communication abilities and disabilities in higher functioning individuals with autism spectrum disorders: the Vineland and the ADOS","volume":"37","author":"Klin","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.ntt.2016.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1542\/peds.2005-0185","article-title":"Factors associated with age of diagnosis among children with autism spectrum disorders","volume":"116","author":"Mandell","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ntt.2016.01.001_bb0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1059-1311(02)00135-8","article-title":"Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate","volume":"11","author":"Mawer","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.ntt.2016.01.001_bb0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","article-title":"In utero antiepileptic drug exposure: fetal death and malformations","volume":"67","author":"Meador","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0125","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ntt.2016.01.001_bb0130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/brain\/awq352","article-title":"Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age","volume":"134","author":"Meador","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ntt.2016.01.001_bb0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ntt.2016.01.001_bb0140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ntt.2016.01.001_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ntt.2016.01.001_bb0150","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0155","first-page":"119","article-title":"The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ntt.2016.01.001_bb0165","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2016.01.001_bb0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2","article-title":"Antiepileptic drug regimens and major congenital abnormalities in the offspring","volume":"46","author":"Samren","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ntt.2016.01.001_bb0175","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1994.03510340057034","article-title":"Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy","volume":"271","author":"Scolnik","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ntt.2016.01.001_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","article-title":"Child development following in utero exposure: levetiracetam vs sodium valproate","volume":"76","author":"Shallcross","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0185","series-title":"Vineland-II: Vineland adaptive behavior scales: survey forms manual","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.ntt.2016.01.001_bb0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yebeh.2008.01.010","article-title":"Motor and mental development of infants exposed to antiepileptic drugs in utero","volume":"13","author":"Thomas","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ntt.2016.01.001_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-8749.2007.02020.x","article-title":"Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development","volume":"50","author":"Titze","year":"2008","journal-title":"Dev. Med. Child Neurol."},{"issue":"7","key":"10.1016\/j.ntt.2016.01.001_bb0200","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2016.01.001_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-1331.2006.01359.x","article-title":"Foetal malformations and seizure control: 52months data of the Australian Pregnancy Registry","volume":"13","author":"Vajda","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ntt.2016.01.001_bb0210","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2016.01.001_bb0215","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.yebeh.2006.08.007","article-title":"The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children","volume":"9","author":"Viinikainen","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ntt.2016.01.001_bb0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","article-title":"Neuropsychological effects of exposure to anticonvulsant medication in utero","volume":"64","author":"Vinten","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2016.01.001_bb0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yebeh.2008.10.011","article-title":"The behavioral consequences of exposure to antiepileptic drugs in utero","volume":"14","author":"Vinten","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ntt.2016.01.001_bb0230","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","article-title":"Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study","volume":"93","author":"Wide","year":"2004","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ntt.2016.01.001_bb0235","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036216300010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036216300010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:21:05Z","timestamp":1760210465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036216300010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":47,"alternative-id":["S0892036216300010"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2016.01.001","relation":{},"ISSN":["0892-0362"],"issn-type":[{"value":"0892-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}